Vol 82, No 3 (2024)
Clinical vignette
Published online: 2023-12-15

open access

Page views 626
Article views/downloads 429
Get Citation

Connect on Social Media

Connect on Social Media

Successful pulmonary artery banding in an infant with idiopathic dilated cardiomyopathy and severe heart failure

Krzysztof Kocot1, Luiza Zalewska2, Grzegorz Zalewski3, Agata Morka4, Lesław Szydłowski1
Pubmed: 38230477
Pol Heart J 2024;82(3):333-334.

Abstract

Not available

CLINICAL VIGNETTE

Successful pulmonary artery banding in an infant with idiopathic dilated cardiomyopathy and severe heart failure

Krzysztof Kocot1Luiza Zalewska2Grzegorz Zalewski3Agata Morka4Lesław Szydłowski1
1Department of Pediatric Cardiology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, Katowice, Poland
2Department of Pediatric Cardiology, John Paul II Upper Silesian Child Health Centre, Katowice, Poland
3Department of Pediatric Cardiac Surgery, John Paul II Upper Silesian Child Health Centre, Katowice, Poland
4Students Scientific Circle at the Department of Pediatric Cardiology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, Katowice, Poland

Correspondence to:

Krzysztof Kocot, MD, PhD,

Department of Pediatric Cardiology,

Faculty of Medical Sciences in Katowice,

Medical University of Silesia,

Medyków 16, 40–752 Katowice, Poland,

phone: +48 32 207 18 59,

e-mail: krzysztof.kocot@sum.edu.pl

Copyright by the Author(s), 2024

DOI: 10.33963/v.phj.97721

Received: September 3, 2023

Accepted: October 1, 2023

Early publication date: December 15, 2023

Childhood dilated cardiomyopathy (DCM) remains a challenge of pediatric cardiology. The 5-year survival free of heart transplantation, is around 50% with the highest death rate in children <1 year old [1]. High waitlist mortality and shortage of smaller donors led to the seek for alternative solutions. Pulmonary artery banding (PAB) in DCM was first described in 2007 [2]. Since then, the method proved to be effective, especially in infants. However, it is still not commonly used worldwide. Fewer than 20 centers presented their results before 2022 [3]. The largest study published so far showed promising results with 34/70 patients experiencing complete left ventricle (LV) functional recovery [4]. The hemodynamic changes induced by PAB result from positive right and LV interaproctions. The increase in right ventricle wall stress results in leftward shift of the intraventricular septum and LV reshaping that further leads to improvement in diastolic and systolic function [5]. However, the exact mechanism, on the cellular level, remains unknown. It is assumed that changes induced by PAB have the potential to reactivate the proliferative potential of cardiomyocytes [3].

We report a case of successful PAB in an infant with idiopathic DCM, despite severe end-stage heart failure (HF) prior to the procedure. The boy was born after 38th week of gestation with birth weight of 2700 grams. He remained healthy until the age of six months old, when the symptoms of HF developed and he was referred to the Pediatric Cardiology Department. Physical examination showed pale skin, severe difficulty breathing, tachycardia, hepatomegaly. Echocardiography revealed severely enlarged LV with ejection fraction (EF) of 10% and moderate mitral regurgitation. Computed tomography scan excluded coronary artery abnormalities. No other specific cause of cardiomyopathy could be found, including carnitine deficiency, most common metabolic diseases and viral infections. Magnetic resonance imaging showed enlarged LV with EF of 8%. The study excluded non-compaction cardiomyopathy, but showed areas of late gadolinium enhancement characteristic for DCM.

The clinical state of the boy deteriorated, despite intensive treatment. He was qualified on the heart transplant waiting list. However, due to further deterioration, the patient was qualified by the Heart Team for a PAB operation. Final pre-surgical echocardiography showed EF of 11% and global longitudinal LV strain of –4% (Figure 1AC; Supplementary material, Videos S1 and S2). At the age of 9-month old the child underwent PAB. The pulmonary artery diameter was reduced by 50% resulting in right ventricular pressure increase to 55% of systemic arterial pressure. After the operation the clinical state of the patient slowly improved. Two months post-surgery the intravenous drugs were withdrawn and after another two months the boy was discharged home with oral HF treatment.

Figure 1. Echocardiographic apical 4-chamber view. A, B, C. Examination prior to PAB. D, E, F. Examination 12 months after PAB. A, D. Right and left ventricular end-diastolic diameters. B, E. LV end diastolic volume. C, F. LV EF
Abbreviations: A4Cd, apical 4-chamber view, diastole; A4Cs, apical 4-chamber view, systole; BP, assessed in biplane (4-chamber and 2-chamber view); Dist, distance; EF, ejection fraction; ESV, end-systolic volume; LV, left ventricle; Vol, volume

During one year of follow up we observed outstanding improvement in LV size and function. Echocardiography at the age of 20 months showed EF of above 60% and global longitudinal strain of –19% (Figure 1DF; Supplementary material, Videos S3 and S4). This improvement was also confirmed by magnetic resonance imaging. The boy developed well, with no signs of HF and was withdrawn from the heart transplant waiting list.

Supplementary material

Supplementary material is available at https://journals.viamedica.pl/polish_heart_journal.

Article information

Conflict of interest: None declared.

Funding: None.

Open access: This article is available in open access under Creative Common Attribution-Non-Commercial-No Derivatives 4.0 International (CC BY-NC-ND 4.0) license, which allows downloading and sharing articles with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially. For commercial use, please contact the journal office at polishheartjournal@ptkardio.pl

REFERENCES

  1. Alvarez JA, Orav EJ, Wilkinson JD, et al. Competing risks for death and cardiac transplantation in children with dilated cardiomyopathy: results from the pediatric cardiomyopathy registry. Circulation. 2011; 124(7): 814823, doi: 10.1161/CIRCULATIONAHA.110.973826, indexed in Pub- med: 21788591.
  2. Schranz D, Veldman A, Bartram U, et al. Pulmonary artery banding for idiopathic dilative cardiomyopathy: a novel therapeutic strategy using an old surgical procedure. J Thorac Cardiovasc Surg. 2007; 134(3): 796797, doi: 10.1016/j.jtcvs.2007.04.044, indexed in Pubmed: 17723838.
  3. Ponzoni M, Castaldi B, Padalino MA. Pulmonary artery banding for dilated cardiomyopathy in children: Returning to the bench from bedside. Children (Basel). 2022; 9(9): 1392, doi: 10.3390/children9091392, indexed in Pubmed: 36138701.
  4. Schranz D, Akintuerk H, Bailey L. Pulmonary artery banding for functional regeneration of end-stage dilated cardiomyopathy in young children: World network report. Circulation. 2018; 137(13): 14101412, doi: 10.1161/CIRCULATIONAHA.117.029360, indexed in Pubmed: 29581368.
  5. Latus H, Hachmann P, Gummel K, et al. Biventricular response to pulmonary artery banding in children with dilated cardiomyopathy. J Heart Lung Transplant. 2016; 35(7): 934938, doi: 10.1016/j.healun.2016.04.012, indexed in Pubmed: 27266806.